HL7 Europe Medication Prescription and Dispense
0.1.0 - ci-build 150

HL7 Europe Medication Prescription and Dispense, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/mpd/ and changes regularly. See the Directory of published versions

Artifacts Summary

Contents:

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Structures: Logical Models

These define data models that represent the domain covered by this implementation guide in more business-friendly terms than the underlying FHIR resources.

A - Prescription

Prescription. Several Sections of the eHN guideline.
A.1.1 Patient administrative data

Patient. Sections A1.1 of the eHN guideline.
A1.4 Identification of the prescribed product

Identification of the prescribed product. Section A1.4 of the eHN guideline
B.1 Dispensation information (provided by the dispensing pharmacy)

Dispensation information (provided by the dispensing pharmacy). Section B1 of the guidelines

Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

Medication: MPD

This profile defines how to represent Medication data on ePrescription and eDispensation
MedicationRequest: MPD

This profile defines how to represent ePrescription or other medication request.
Patient: MPD

This profile defines how to represent Patient in HL7 FHIR for the purpose of this guide.

Structures: Extension Definitions

These define constraints on FHIR data types for systems conforming to this implementation guide.

Medication - Characteristic

Any characteristic of the medicinal product prescribed or dispensed (for example, price, textual package description, special program information, etc)
Medication - Classification

Medication classification/category. Allows the product to be classified by various systems, e.g ATC, narcotic class, legal status of supply, etc..
Medication - Device

Device, typically an administration device, included in the medicinal product.
Medication - Product Name

Name of the medicinal product. This is typically the name of a real product as registered. This element should not contain display names of virtual product concepts.
Medication - Size of Item

Size of a manufactured item or unit of presentation. For example, size of one vial in a package that may contain several vials.
Medication - Strength substance

Substance for marking the basis of strength. When the precise active ingredient is a salt, the strength is often provided for the active moiety (basis of strength).
Medication - Strength type

Strength type (e.g. concentration strength, presentation strength)
Medication - Unit of presentation

Unit of presentation, typically describing the smallest countable package item (e.g tablet, vial, ampoule, etc). Unit of presentation is also often used in describing pack size and the denominator of strength. If the size of presentation unit is relevant, it should be described in sizeOfItem extension.

Terminology: Concept Maps

These define transformations to convert between codes by systems conforming with this implementation guide.

eHN Subject to this guide Map

eHN ePrescription Model to this guide Map

Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

01A-Cefuroxime1500GenericExplicit

1A. Cefuroxime 1500mg (1.5g) powder for solution in a vial. Generic product, defined by attributes.
01B-Cefuroxime1500GenericConcept

1B. Cefuroxime 1500mg (1.5g) powder for solution in a vial. Generic product, defined by a code system (receiving system is expected to have access to the code system for additional attributes or display names).
01C-Cefuroxime1500Branded

1C. Cefuroxime 1500mg (1.5g) powder for solution in a vial. Branded packaged product, defined by attributes.
02A-ClotrimazoleCanifugCremolum

2A. Clotrimazole cream 10mg/g and 6 pessaries 100g. Branded packaged product, consisting of different medication items. Defined by attributes.
02A1-CanifugCremolumCreamItem

2A2. Clotrimazole cream (10mg/g, 1 tube of 20g) as part of Canifug Cremolum product (ISO IDMP manufactured item)
02A2-CanifugCremolumPessaryItem

2A1. Clotrimazole pessary (6 pessaries of 100mg) as part of Canifug Cremolum product (ISO IDMP manufactured item)
03B-VitaminBComplexBranded

3B. Milgamma N, B-vitamin complex. Branded packaged product, defined by attributes.
04-FirmagonBranded
  1. Firmagon. Branded packaged product, defined by attributes, includes administration devices.
05A-Tilidin-Branded

05A. Tilidin (50mg), Naloxon (4mg) oral drops. Branded packaged product, defined by attributes. Unusual strength.